There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The aim of this study was to evaluate the cost-effectiveness of insulin degludec (IDeg)
vs insulin glargine (IGlar) as part of a basal-bolus treatment regimen in adults with
T1DM, using a short-term economic model.